Intervention for Alcohol Drinking

Phase-Based Progress Estimates
University of Washington, Seattle, WA
Alcohol Drinking+1 More
Drinking to Cope CBT skills - Behavioral
18 - 65
All Sexes
What conditions do you have?

Study Summary

A total of 120 young adults who drink to cope with negative affect will be randomized to a 4-week, web-based intervention with interactive modules on cognitive-behavioral skills (n=60) or an assessment only control (n=60). Participants will complete 4 weekly assessments and a 1- and 3-month follow-up.

Eligible Conditions

  • Alcohol Drinking
  • Skills, Coping

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: past month

Past Month
Alcohol Coping
Alcohol Negative Consequences
Past month
Depressive Symptoms
past month
Alcohol Use

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
Assessment Control
1 of 2
Active Control

120 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention · No Placebo Group · N/A

ActiveComparator Group · 1 Intervention: Drinking to Cope CBT skills · Intervention Types: Behavioral
Assessment ControlNoIntervention Group · 1 Intervention: Assessment Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: past month
Closest Location: University of Washington · Seattle, WA
Photo of university of washington 1Photo of university of washington 2Photo of university of washington 3
1993First Recorded Clinical Trial
8 TrialsResearching Alcohol Drinking
629 CompletedClinical Trials

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
692 Previous Clinical Trials
1,167,989 Total Patients Enrolled
226 Trials studying Alcohol Drinking
74,325 Patients Enrolled for Alcohol Drinking
University of WashingtonLead Sponsor
1,571 Previous Clinical Trials
1,567,876 Total Patients Enrolled
21 Trials studying Alcohol Drinking
5,844 Patients Enrolled for Alcohol Drinking
Jennifer M Cadigan, PhDPrincipal InvestigatorUniversity of Washington

Eligibility Criteria

Age 18 - 65 · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.